As components of the mCRM System, the devices are designed to work together wirelessly to coordinate painless intracardiac anti-tachycardia pacing (ATP) therapy, provide rate-responsive bradycardia ...
(RTTNews) - Boston Scientific Corporation (BSX), a manufacturer of medical devices said on Thursday that has initiated the MODULAR ATP clinical trial to evaluate the safety, performance, and ...
MARLBOROUGH, Mass., May 18, 2024 /PRNewswire/ -- Boston Scientific Corporation (BSX) today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRM™ System, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results